Abstract
Introduction
MICA and MICB proteins are a family of polymorphic genes mapping within the MHC region, from which they receive their name, MHC class I-related Chain A and B [1] . However, in contrast to MHC class I molecules, MICA/B do not associate with β2-microglobulin or present antigenic peptides, nor are they expressed constitutively. Instead their expression is induced on many types of tumour cells and after infection by viruses or intracellular bacteria [2] . They bind the activating immune receptor NKG2D, constitutively expressed on all NK cells as well as CD8 + αβ T cells and γδ T cells [3] . The recognition by NKG2D of its ligands expressed on target cells induces lysis and cytokine secretion by NK cells and T cells.
However, MICA/B proteins can also be shed from cells and interaction with these soluble proteins leads to loss of cell surface NKG2D receptor and lymphocyte unresponsiveness [2, 4] . Indeed, the presence of high levels of soluble NKG2D-ligands in patient serum is a marker for poor prognosis in various types of cancer [5] [6] [7] . Thus it seems clear that the regulation of expression and shedding of MICA/B molecules plays an important role in the regulation of the function of the cytotoxic lymphocytes of the immune system [8] .
Previous studies have shown that proteolytic cleavage of MICA/B depends on metalloproteases [9, 10] , specifically, the ADAM (A Disintegrin And Metalloproteinase) family members, ADAM9, ADAM10 and ADAM17 (also known as TACE, TNF-Alpha-Converting Enzyme) [11] [12] [13] and the matrix metalloprotease MMP14 [14] . However, these metalloproteases are all rather widely expressed suggesting that there may be other levels of regulation of MICA/B shedding. The thiol isomerase ERp5 is another protein that has been reported to influence the shedding of MICA molecules [15] . The recruitment of MICB molecules into cholesterol and sphingolipid enriched microdomains (detergent-resistant membranes, DRMs) has also been suggested to aid efficient proteolytic release of these molecules [12] , as treatment of cells with an inhibitor of palmitoylation was shown to block the recruitment of MICB molecules to DRMs and to reduce the shedding of MICB molecules.
However, while treatment with the palmitate analog 2-bromo-palmitate has been widely used to inhibit the palmitoylation of proteins [16] , this is not a particularly selective agent, moreover, the mechanism by which it inhibits palmitoylation is unknown [17] . Palmitoylation refers to the addition of a 16-carbon fatty acid by thioester linkage to cysteine residues, although proteins can be modified by a variety of fatty acids with different chain lengths and insaturations. For this reason, the term palmitoylation is used in a general manner of referring to S-acylation. It has been suggested that S-acylation preferentially targets molecules possessing transmembrane domains to specialised microdomains of the cell membranes enriched in cholesterol, DRMs, also called lipid rafts [18] . MICA and MICB contain two conserved juxtatransmembrane cysteines which are putative sites for palmitoylation. In this paper, a MICA molecule, where these cysteines have been mutated to serines, is shown to be defective in palmitoylation and recruitment to DRMs. Using this MICA palmitoylation mutant we have studied the functional role of this modification for both DRM localisation and MICA function. In particular, the shedding of soluble MIC molecules and immune recognition by NK cells were analysed.
Results

MICA can be palmitoylated on cysteine residues in the cytoplasmic tail
We have reported that the recruitment of MIC to DRMs was important for efficient shedding of these molecules [12] . Here we have investigated the molecular basis governing the association of MIC to these cholesterol and sphingolipid enriched domains. Previously, treatment of cells with 2-bromo-palmitate, an inhibitor of protein palmitoylation, was shown to markedly reduce both shedding of soluble MIC molecules and the recruitment of MICA/B to DRMs, suggesting that palmitoylation might be a prerequisite for recruitment of MICA/B proteins to cholesterol enriched microdomains, could be palmitoylation. Both MICA and MICB contain two cysteines at the cytoplasmic tail ( Figure 1A ) that are putative sites of palmitoylation. Thus the relevance of these cysteines for recruitment of MICA into cholesterol-enriched membrane domains was investigated by mutagenesis: the Cys residues in position 306 and 307 were mutated into serines (MICA2CS) ( Figure 1A ). Both the MICA wild type and MICA2CS palmitoylation mutant molecules were stably expressed in CHO cells (CHO-MICA and CHO-MICA2CS) and similar cell surface expression of the wild-type and mutant molecules was observed by flow cytometry ( Figure 1B ). Next, a non-radioactive labelling method based on the substitution of the metabolically labelled fatty acid by a biotinylated probe [19, 20] was used to investigate the level of palmitoylation of the wild-type and the mutant MICA molecules. CHO cells transfected with MICA or MICA2CS were labelled with ω-azido pentadecanoic acid and lysed. After immunoprecipitation and click chemistry labeling, fatty acid-modified proteins became biotinylated and could be visualised on western blot analysis with streptavidin-HRP ( Figure 1C ). Palmitoylated MICA was observed for the wild-type transfectant, however mutation of the cysteine residues led to the absence of detectable palmitoylation of MICA molecules. The positive control protein caveolin-1 was shown to be palmitoylated in both preparations and equal amounts of MICA molecules were present in the lysates. Thus, this experiment confirmed a previous report indicating that MICA molecules could be palmitoylated [21] and demonstrated that the paired cysteines 306 and 307 of the cytoplasmic tail are necessary for palmitoylation of MICA.
Palmitoylation of MICA is relevant for its association with membrane microdomains enriched in cholesterol (DRMs)
It is known that palmitoylation may affect the trafficking and stability of proteins [22] .
However, pulse-chase experiments showed that the EndoH resistant band that corresponds to the mature form of the protein appears in both MICA and MICA2CS with similar kinetics confirming that the maturation rate of MICA was not altered by the mutation of the Cys residues in the cytoplasmic tail (data not shown). Next, since covalent modification with palmitic acid has been shown to be important for the association of various transmembrane proteins with DRMs, we studied whether palmitoylation was part of the molecular basis for the recruitment of MICA to DRMs. For these experiments, a well established biochemical approach based on the solubilization of membranes using non-ionic detergents, followed by fractionation in sucrose gradients [23] was used. To assess the efficiency of fractionation, the protein caveolin-1 was included as a marker of the fractionation. In our CHO transfectant system, although the majority of MICA proteins were present in the soluble fractions, a proportion of these molecules was also present in caveolin-1 positive fractions, suggesting that MICA could be recruited to DRMs (Figure 2A ). When the MICA2CS palmitoylation mutant was analysed, no MICA molecules were found in the DRM fractions. These data demonstrate that palmitoylation of these juxtamembrane Cys residues in the cytoplasmic tail is essential for the MICA partition into DRM microdomains.
The presence of MICA in DRMs poses the question whether they would be also included in the specialized invaginations of the membrane known as caveolae. These are quite stable, specialised membrane invaginations that under certain circumstances can become internalized [24] . To investigate the presence of MICA in caveolae, coimmunoprecipitation experiments of MIC and caveolin-1 were performed. Caveolin-1 was This decreased shedding of the MICA2CS protein was also seen in U373 transfectants demonstrating that this effect did not depend on the identity of the transfected cell (Supporting Information Figure 1 ). Moreover, the residual level of shedding from the MICA2CS transfectant was largely independent of the activity of several proteases, except for metalloproteases ( Figure 3B ). The inhibition of MICA shedding seen after treatment with the broad spectrum metalloprotease inhibitor BB94 was statistically significant (p<0.05) whereas no other inhibitor significantly changed the shedding of MICA2CS. These findings support the idea that palmitoylation of MICA and recruitment to DRMs is important for efficient proteolytic release of soluble MICA molecules and suggest that the decreased shedding of MICA/B observed on treatment with inhibitors of palmitoylation was due to blockade of recruitment of MICA/B to DRMs rather than any effect of the inhibitor on ADAM17/TACE [12] .
The absence of Cys motifs in MICA does not affect NK cell cytotoxicity
To evaluate the effects of MICA palmitoylation for NK cell recognition, the abilities of the MICA wild-type and A2CS transfectants to activate cytotoxicity were compared using Figure 3 ). It has been suggested that the threshold of stimulation needed to trigger cytotoxicity and IFN-γ production are different [25] , however the MICA and MICA2CS transfectants were equally able to stimulate production of IFN-γ by polyclonal NK cell lines maintained in IL-2 ( Figure 5B, Supporting Information Figure 3) . Therefore, overall, these results suggest that the addition of palmitic acid to MICA and the recruitment of palmitoylated MICA to DRMs are not contributing to target cell recognition by NK cells.
Discussion
The data presented in this paper demonstrate that palmitoylation of the cysteine residues present in the cytoplasmic tail of MICA is a key modification for its recruitment into DRM microdomains, since a mutant MICA molecule, lacking the two conserved cysteines, was absent from these specialised membrane microdomains. The proximity between MICA and caveolin-1, the main component of caveolae, was also demonstrated. Assessment of the functional implications of palmitoylation on MICA revealed that the loss of the two conserved cysteines in the cytoplasmic tail was associated with a decrease in the proteolytic release of MICA. In contrast, the lack of palmitoylation of MICA, and the consequent absence of this molecule in cholesterol and sphingolipid enriched domains at the plasma membrane does not seem to have a major impact on NK cell recognition and cytotoxic activity mediated by the NKG2D receptor.
The data presented here suggest that the recruitment of MICA into specialised microdomains has a major significance in the release of these ligands as soluble molecules.
The presence of soluble NKG2D-ligands can affect the function of NK cell and T cell effector immune cells as has been demonstrated both in vitro and in vivo using animal models [4, 26, 27] . These observations are consistent with previous data showing that although only a relatively small proportion of MICA is found in DRMs, the presence of MIC molecules in these microdomains is critical for efficient proteolytic release of soluble MIC molecules [12] .
In fact, published data showed that treatment of cells with inhibitors of palmitoylation reduces the release of soluble MICB molecules and treatment with broad spectrum inhibitors of metalloproteases increases the fraction of MICB molecules found in DRMs. Here, we used a cleaner, more specific, system to eliminate palmitoylation by mutation of cysteine residues, and demonstrated that this modification is indeed responsible for the inclusion of MICA in DRMs and participates in shedding of the molecule.
Only a proportion of the MICA proteins are palmitoylated within the cell and this is not surprising since it is known that several proteins can undergo successive cycles of palmitoylation and depalmitoylation mediated by palmitoyl acyl transferases, adding palmitic acid molecules, which can be removed by cytosolic acyl-protein thioesterases [28] . Since protein palmitoylation is a reversible modification that can be dynamically regulated by extracellular stimuli [29] , it would be interesting to investigate whether MICA palmitoylation can be modulated by cellular stress such as infection or tumour transformation, thus influencing the localisation of MICA molecules in the cholesterol enriched microdomains of the membranes, and so MICA shedding. However, the biological significance of protein palmitoylation of transmembrane molecules includes more than just recruitment to DRMs. As happens with other proteins, palmitoylation of MICA could also affect the trafficking, endocytosis and stability of this molecule. For example, it is known that palmitoylation can protect proteins from ubiquitylation and degradation [30] . Virally-induced ubiquitylation of MICA has been reported [31] and it is interesting to note that the cysteine substrates for palmitoylation are adjacent to the lysine residues of MICA that are ubiquitylated by the Kaposi's sarcoma-associated herpesvirus ubiquitin ligase [31] . In other systems, protein depalmitoylation followed by ubiquitination promotes internalisation and sorting to intracellular compartments such as multivesicular bodies (MVB) that ultimately fuse with lysosomes or with the plasma membrane to release exosomes [32] . These observations reinforce the idea that palmitoylation, ubiquitylation and endocytosis of MICA are important aspects of the cell biology of these molecules that could happen either sequentially or in cycles and this needs further investigation. In this context it is interesting to note that MICA co-immunoprecipitated with caveolin-1, while a mutant MICA lacking the two cysteines in the cytoplasmic tail did not co-precipitate with caveolin-1. These data suggest that MICA is found in the same membrane microdomains as caveolin-1 and, given the clear association of the predominantly caveolae-associated protein caveolin-1 with endocytosis [33] , pose the question of whether the association with caveolin is relevant for clathrin-independent endocytosis of MICA.
Similarly, the observation that the localization of the matrix metalloproteinase MT1-MMP to caveolin-enriched domains has an important effect on the control of its enzymatic activity [34, 35] , raises the question of whether the presence of MICA in caveolae is relevant for shedding.
The NKG2D receptor has been shown to localise to cholesterol enriched domains upon NK cell activation [36] . However, the relevance of this recruitment of both receptor and ligands to DRMs during the NK cell-target cell interaction is unclear. Here we demonstrate that the lack of two cysteine residues at the beginning of the cytoplasmic tail of MICA does not significantly affect the ability of these mutant molecules to stimulate cytotoxic activity or IFN-γ production by either resting or IL-2 activated NK cells. These results are consistent with our recent study, showing that a naturally occurring transmembrane form of ULBP2 was as capable of enhancing NK cell activation as the GPI-linked form of ULBP2 [37] . In contrast, Martinez et al. [38] have observed that redistribution of ULBP1 outside of DRM, through the replacement of the GPI linkage in ULBP1 by a transmembrane region of CD45, resulted in diminished NK cell responses to P815 cells expressing these molecules. The specific contribution of various transmembrane regions to the distribution and properties of receptor ligands on target cells has yet to be explored. Our data differ also from the observations of Eleme et al. who reported that a truncated form of MICA lacking the complete cytoplasmic tail, including the putative site for S-acylation, was expressed at the cell surface but was unable to overcome inhibition of NK cell cytotoxicity, as wild-type MICA did [21] . However, an important difference between those experiments and ours is that the mutant MICA molecule studied by Eleme et al. lacked the whole cytoplasmic tail, suggesting that some other region or modification of the cytoplasmic tail of MICA might be important for the regulation of NK cell cytotoxicity.
One important question in the field of NKG2D is why a single receptor has such a variety of different ligands, including a large number of alleles for MICA/B and two families of proteins with different transmembrane attachments. Since all of them seem to be able to recognise NKG2D receptor, variability seems to be important for regulation of the surface expression and release of NKG2D-ligands. Variation thus could play an important role in the adaptation of the cell to different stress situations and/or pathogen infection. The data presented here support the idea that modifications at the C-terminal region of NKG2D-ligands affects important aspects of the biology of these proteins such as inclusion in membrane microdomains and shedding, but not receptor-ligand recognition.
Materials and Methods
Site directed mutagenesis
A construct encoding a MIC molecule where cysteines 306 and 307 in the cytoplasmic tail were mutated to serine residues (MICA2CS) was prepared by PCR (Quikchange mutagenesis kit, Stratagene), using a plasmid containing the MICA*019 allele as template [39] and the oligonucleotides (Sigma-Genosys Ltd): 5'TTC TAT GTC CGT TcT TcT AAG AAG AAA ACA TCA GC3' and 5'GC TGA TGT TTT CTT CTT AgA AgA ACG GAC ATA GAA3' (lower case indicates the nucleotides mutated). The integrity of the MICA2CS plasmid construct was verified by DNA sequencing analysis. A schematic representation of the wild-type and mutant constructs is depicted in Figure 1A .
Cells
Chinese Hamster Ovary cells (CHO) were maintained in Hams F12 medium supplemented with 10% fetal calf serum. For transfection, the expression plasmids encoding either MICA*019 or MICA2CS were mixed (9:1 ratio) with a vector conferring resistance to puromycin [40] , then CHO cells were transfected with this mixture using Lipofectamine 2000. 
DRMs fractionation
Detergent resistant membranes (DRMs) isolation was performed as described previously [12] . Briefly, 20 x 10 6 CHO-MICA and CHO-MICA2CS cells were lysed in TNE buffer (20 mM Tris pH 7.5, 150 mM NaCl, 5 mM EDTA) containing 1% Brij-58 (Sigma) and protease inhibitors (1 μM leupeptin and 1 μM pepstatin). Lysates were homogenised with 10 strokes with a Dounce homogeniser, diluted with an equal volume of 85% sucrose in TNE and then placed at the bottom of clear ultra centrifuge tubes. A discontinuous sucrose gradient was overlaid on top of this suspension (6 ml of 30% sucrose and 4 ml of 5% sucrose, both in TNE). Samples were centrifuged at 200,000 g at 4°C for 20 hours. 1 ml fractions were collected from the top to bottom, and deoxycholate (DOC) was added to a final concentration of 0.2%. Samples were analysed by SDS-PAGE and western blot.
Western blot
Samples were analysed on 12% SDS-PAGE gels and transferred to Immobilon-P (Millipore). Membranes were blocked using 5% non-fat dry milk in PBS containing 0.1%
Tween-20 and incubated with goat polyclonal biotinylated anti-MICA/B antibody (R&D systems) or anti-caveolin-1 (BD Transduction Laboratories) for 1 hour, followed by a horseradish peroxidase-conjugated secondary reagent. Proteins were visualized using the ECL system (GE Healthcare).
Detection of palmitoylated proteins
Protein palmitoylation was analysed using a novel, non-radioactive approach [19, 20, 41] . This procedure is based on the metabolic labelling of cells with a palmitic acid analogue and click chemistry. CHO-MICA and CHO-MICA2CS cells stably transfected with MICA or MICA2CS were washed with PBS and pre-treated with 10 μM GM6001 in serum free Hams-F12 medium during 30 minutes to minimise the loss of MICA molecules by shedding. Cells were then metabolically labelled by adding 100 μM ω-azido pentadecanoic acid for 2 hours at 37ºC in 5% CO 2 . Cells were washed in PBS, harvested and lysed in buffer containing 50 mM triethanolamine pH 7.4, 5 mM MgCl 2 , 150 mM NaCl, 1% NP-40, 1 μM leupeptin and 1 μM pepstatin for 30 min at 4ºC. Post-nuclear lysates were obtained by centrifugation at 20,000 g.
Lysates were precleared with Pansorbin (Merk) and immunoprecipitated with either anti-MICA antibodies (AMO1 and 6D4). Caveolin-1 protein was used as a positive control.
Immunoprecipitated proteins were recovered with Protein G sepharose beads. Beads were resuspended in lysis buffer containing 4% SDS, and fatty acid labelled proteins were biotinylated by chemoselective reaction with 100 μM alkyne-biotin, 1 mM Tris(2-carboxyethyl)phosphine (TCEP, Pierce), 100 μM Tris-(benzyltriazolylmethyl)amine (TBTA, Sigma) and 1 mM CuSO 4 for 1 h at room temperature. Click reactions were terminated by the addition of SDS-PAGE loading buffer. Samples were analysed by SDS-PAGE and Western blot where streptavidin-HRP was used as detection reagent to visualise biotinylated, and hence, palmitoylated immunoprecipitated MICA and caveolin-1.
Immunoprecipitation
Cells were lysed in 50 mM Tris pH 7.6, 150 mM NaCl, 5 mM EDTA, 1 µg/ml leupeptin, 1 µg/ml pepstatin and 1% Brij-58. Nuclei were removed by centrifugation and lysates were precleared by incubation with Pansorbin. Anti-caveolin-1 antibodies were added to lysates, incubated for 1 hour and recovered using Protein A sepharose beads (Pharmacia). Rabbit Ig was used as a negative control. Beads were washed three times and resuspended in SDS-PAGE-loading buffer. Samples were resolved in SDS-PAGE and western blot was performed using biotinylated goat polyclonal antibodies against MICA/B (R&D systems). 
ELISA
Cytotoxicity assays
NK cell cytotoxicity was evaluated by non-radioactive, cytotoxicity assays based on timeresolved fluorometry assays as described [42] . 
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